Variant report
Variant | rs17482961 |
---|---|
Chromosome Location | chr2:111791077-111791078 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:111786000-111795800 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr2:111786200-111792400 | Enhancers | Fetal Lung | lung |
3 | chr2:111786800-111792800 | Enhancers | Fetal Intestine Small | intestine |
4 | chr2:111787000-111792000 | Enhancers | Stomach Mucosa | stomach |
5 | chr2:111787000-111792800 | Enhancers | Fetal Intestine Large | intestine |
6 | chr2:111787400-111795600 | Weak transcription | H1 Cell Line | embryonic stem cell |
7 | chr2:111787800-111825400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr2:111788000-111791200 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
9 | chr2:111788000-111791600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
10 | chr2:111788200-111791200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr2:111788200-111792600 | Weak transcription | H9 Cell Line | embryonic stem cell |
12 | chr2:111788200-111793400 | Weak transcription | Fetal Thymus | thymus |
13 | chr2:111788200-111799200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr2:111788600-111791400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
15 | chr2:111789200-111791200 | Enhancers | Left Ventricle | heart |
16 | chr2:111789200-111791200 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
17 | chr2:111789400-111791200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr2:111789600-111791200 | Enhancers | Placenta | Placenta |
19 | chr2:111790000-111791400 | Flanking Active TSS | Rectal Mucosa Donor 29 | rectum |
20 | chr2:111790200-111791200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
21 | chr2:111790200-111791200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
22 | chr2:111790200-111791400 | Enhancers | Primary B cells from cord blood | blood |
23 | chr2:111790200-111791400 | Enhancers | NHEK | skin |
24 | chr2:111790200-111791600 | Enhancers | HMEC | breast |
25 | chr2:111790200-111792400 | Enhancers | Fetal Heart | heart |
26 | chr2:111790400-111791200 | Enhancers | Gastric | stomach |
27 | chr2:111790400-111791200 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
28 | chr2:111790800-111791200 | Enhancers | A549 | lung |
29 | chr2:111790800-111791200 | Enhancers | HepG2 | liver |
30 | chr2:111790800-111791600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
31 | chr2:111790800-111793600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
32 | chr2:111790800-111799200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
33 | chr2:111790800-111800200 | Weak transcription | Spleen | Spleen |
34 | chr2:111791000-111791200 | Flanking Active TSS | Colonic Mucosa | Colon |
35 | chr2:111791000-111791200 | Flanking Active TSS | Duodenum Mucosa | Duodenum |